#Drug_Delivery
Continuity Biosciences Launches Groundbreaking Clinical Trial for Pancreatic Cancer Treatment#USA#pancreatic_cancer#Cary,_NC#Drug_Delivery#Continuity_Biosciences
Continuity Biosciences Launches Groundbreaking Clinical Trial for Pancreatic Cancer Treatment
Continuity Biosciences has begun its first human clinical trial for pancreatic cancer, targeting enhanced drug delivery methods for better outcomes.
third-news.com
May 20, 2026 at 12:55 PM
Innovative Drug Delivery System Developed by Pusan National University Researchers to Combat Colorectal Cancer Effectively#South_Korea#Pusan_National_University#Busan#Colorectal_Cancer#Drug_Delivery
Innovative Drug Delivery System Developed by Pusan National University Researchers to Combat Colorectal Cancer Effectively
Researchers from Pusan National University have created self-protecting nanoparticles for colorectal cancer treatment, enhancing targeted drug delivery and efficacy.
third-news.com
February 19, 2025 at 1:35 PM
The Surge of Global Nanomedicine Market Expected to Reach USD 581.2 Billion by 2034#India#Pune#Precision_Medicine#Drug_Delivery#nanomedicine
The Surge of Global Nanomedicine Market Expected to Reach USD 581.2 Billion by 2034
The global nanomedicine market is projected to experience substantial growth, aiming to hit USD 581.2 billion by 2034, driven by advancements in diagnostics and treatments.
third-news.com
September 25, 2026 at 12:10 AM
Wonderful to see our RSC Pharmaceutics Advisory Board member, Twan Lammers, being elected to the College of Fellow of the American Institute for Medical and Biological Engineering! @twanlammers.bsky.social

Congratulations Twan!

Read more below:

www.linkedin.com/posts/profil...
#biomedical_engineering #nanomedicine #drug_delivery #molecular_imaging | Profile Areas of RWTH Aachen University
Prof. Dr. Twan Lammers from the Institute for Experimental Molecular Imaging at RWTH Aachen University and member of MedST Profile Area has been elected to the College of Fellows of the American Insti...
www.linkedin.com
April 24, 2025 at 3:38 PM
Global Exosomes Market Predicted to Exceed USD 2 Billion by 2034 Driven by Drug Delivery and Medical Innovations#India#Pune#biotechnology#Exosomes#Drug_Delivery
Global Exosomes Market Predicted to Exceed USD 2 Billion by 2034 Driven by Drug Delivery and Medical Innovations
The Global Exosomes Market is set to grow substantially, reaching USD 2,250 million by 2034. Accelerating advancements in drug delivery and regenerative medicine will drive this expansion.
third-news.com
September 22, 2026 at 10:09 PM
The Long-Acting Drugs Market Set for Significant Growth, Reaching $13.3 Billion by 2033#None#Chronic_Diseases#Drug_Delivery#Long-Acting_Drugs
The Long-Acting Drugs Market Set for Significant Growth, Reaching $13.3 Billion by 2033
The long-acting drugs market is anticipated to grow from $7.2 billion in 2026 to $13.3 billion by 2033, spurred by rising chronic diseases and innovative drug delivery solutions.
third-news.com
June 30, 2026 at 2:47 PM
Microneedle Drug Delivery Systems Market Set to Hit $1.6 Billion by 2036 with Innovative Technologies#None#Drug_Delivery#microneedles#Vaccine_Patches
Microneedle Drug Delivery Systems Market Set to Hit $1.6 Billion by 2036 with Innovative Technologies
The microneedle drug delivery systems market is anticipated to surge to $1.6 billion by 2036, driven by innovative technologies focusing on painless and self-administered therapies.
third-news.com
May 14, 2026 at 12:00 AM
Portal Instruments Advances PRIME NEXUS™ with New Development Agreement for Clinical Readiness#USA#Boston#Drug_Delivery#PRIME_NEXUS™#Portal_Instruments
Portal Instruments Advances PRIME NEXUS™ with New Development Agreement for Clinical Readiness
Portal Instruments has signed a major agreement to further develop its PRIME NEXUS™, a groundbreaking autoinjector, preparing it for clinical use by 2027.
third-news.com
March 17, 2026 at 4:04 PM
The Global Nanomedicine Market is Set to Exceed $550 Billion by 2034 with Innovative Drug Delivery Advancements#None#DelveInsight#Drug_Delivery#nanomedicine
The Global Nanomedicine Market is Set to Exceed $550 Billion by 2034 with Innovative Drug Delivery Advancements
With escalating demand for precision treatments, the global nanomedicine market is projected to surpass $550 billion by 2034. Innovative drug delivery technologies are vital to this expansion.
third-news.com
March 4, 2026 at 11:08 PM
Prefilled Auto Injectors Market Expected to Reach USD 11.2 Billion by 2033 Driven by Fast Growth Trends#None#Chronic_Diseases#Drug_Delivery#Auto_Injectors
Prefilled Auto Injectors Market Expected to Reach USD 11.2 Billion by 2033 Driven by Fast Growth Trends
The global prefilled auto injectors market is forecasted to expand significantly, driven by increasing chronic disease incidences and a push for patient-centered care solutions.
third-news.com
February 3, 2026 at 5:20 PM
Piramal Pharma Solutions Unveils Advanced Capsule Tablet Technology for Customized Patient Treatment#India#Mumbai#Patient_Care#Drug_Delivery#Piramal_Pharma
Piramal Pharma Solutions Unveils Advanced Capsule Tablet Technology for Customized Patient Treatment
Piramal Pharma Solutions showcases its tablet-in-capsule technology, enhancing flexibility and customization in patient care through innovative drug delivery systems.
third-news.com
February 3, 2026 at 12:08 PM
Piramal Pharma Solutions Launches Innovative Tablet-in-Capsule Technology for Enhanced Drug Delivery#India#Mumbai#Drug_Delivery#Piramal_Pharma#Tablet-in-Capsule
Piramal Pharma Solutions Launches Innovative Tablet-in-Capsule Technology for Enhanced Drug Delivery
Piramal Pharma Solutions has unveiled its cutting-edge tablet-in-capsule technology, aiming to revolutionize dosage flexibility and patient adherence in oral drug therapies.
third-news.com
February 2, 2026 at 6:21 PM
Piramal Pharma Solutions Unveils Innovative Tablet-in-Capsule Technology for Enhanced Patient Care#India#Ahmedabad#Drug_Delivery#Piramal_Pharma#Tablet-in-Capsule
Piramal Pharma Solutions Unveils Innovative Tablet-in-Capsule Technology for Enhanced Patient Care
Piramal Pharma Solutions has innovated with its new tablet-in-capsule technology, enhancing drug delivery systems for better patient outcomes.
third-news.com
February 2, 2026 at 4:51 PM
Global Nanomedicine Market Set to Surge to $389.52 Billion by 2033 Driven by Targeted Therapies and Drug Delivery Advancements#United_States#Austin#targeted_therapies#Drug_Delivery#nanomedicine
Global Nanomedicine Market Set to Surge to $389.52 Billion by 2033 Driven by Targeted Therapies and Drug Delivery Advancements
The global nanomedicine market is projected to skyrocket to $389.52 billion by 2033 driven by demand for advanced therapies and drug delivery systems, expanding innovation across the industry.
third-news.com
October 13, 2025 at 3:22 PM
Frame Bio Secures Licensing for Innovative Drug Delivery Technology to Aid Regenerative Medicine#United_States#Santa_Fe#Drug_Delivery#Frame_Bio#Mercury_Bio
Frame Bio Secures Licensing for Innovative Drug Delivery Technology to Aid Regenerative Medicine
Frame Bio has announced a strategic licensing agreement with Mercury Bio, gaining access to novel drug delivery technology aimed at treating bone and collagen disorders effectively.
third-news.com
September 17, 2025 at 1:19 PM